MOSCOW (Sputnik) – An application for an emergency use authorization of Sputnik Light, the single-dose version of the Sputnik V COVID-19 vaccine, has been filed in Russia and several other countries, the vaccine’s Twitter account said on Sunday.
On Saturday, Moscow Deputy Mayor Anastasia Rakova said that the first volunteers participating in the Sputnik Light clinical trials have been inoculated. The Russian Health Ministry has greenlighted the clinical trials and their advancement to phase three.
A researcher works inside a laboratory of the Gamaleya Scientific Research Institute of Epidemiology and Microbiology where the world’s first coronavirus vaccine registered in Russia was developed, in Moscow, Russia
According to Kirill Dmitriev, the CEO of the Russian Direct Investment Fund (RDIF), Sputnik V is a vaccine platform rather than just one vaccine. The RDIF CEO has specified that Russia would prioritise the use of Sputnik V while the single-dose version is mainly intended for external markets, especially for countries where the COVID-19 situation remains tough.